Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 26, 2020	Sep. 27, 2019
Current assets:
Cash and cash equivalents	$ 855,103	$ 797,210
Restricted cash	8,290	8,383
Short-term investments	189,383	119,146
Accounts receivable, net of allowance for doubtful accounts of $14,292 and $9,775	247,486	189,115
Contract assets	128,319	195,651
Inventories, net	29,330	32,331
Prepaid expenses and other current assets	45,524	39,704
Total current assets	1,503,435	1,381,540
Long-term investments	74,768	179,587
Property, plant, and equipment, net	546,650	537,432
Operating lease right-of-use assets	78,374	0
Intangible assets, net	160,069	180,891
Goodwill	335,694	334,829
Other non-current assets	100,901	93,395
Deferred taxes	104,015	114,075
Total assets	2,903,906	2,821,749
Current liabilities:
Accounts payable	10,047	15,212
Accrued liabilities	210,241	268,144
Income taxes payable	3,071	3,506
Contract liabilities	18,025	19,991
Operating lease liabilities	16,318	0
Total current liabilities	257,702	306,853
Non-current contract liabilities	24,128	24,404
Non-current operating lease liabilities	65,189	0
Other non-current liabilities	119,990	177,462
Total liabilities	467,009	508,719
Stockholders’ equity:
Retained earnings	2,448,389	2,327,877
Accumulated other comprehensive (loss)	(17,121)	(20,625)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,431,367	2,307,351
Controlling interest	5,530	5,679
Total stockholders’ equity	2,436,897	2,313,030
Total liabilities and stockholders’ equity	2,903,906	2,821,749
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,338,677 shares issued and outstanding at June 26, 2020 and 63,911,270 at September 27, 2019
Stockholders’ equity:
Common stock	58	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,222,720 shares issued and outstanding at June 26, 2020 and 36,229,820 at September 27, 2019
Stockholders’ equity:
Common stock	$ 41	$ 41